JP2018506575A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506575A5
JP2018506575A5 JP2017545684A JP2017545684A JP2018506575A5 JP 2018506575 A5 JP2018506575 A5 JP 2018506575A5 JP 2017545684 A JP2017545684 A JP 2017545684A JP 2017545684 A JP2017545684 A JP 2017545684A JP 2018506575 A5 JP2018506575 A5 JP 2018506575A5
Authority
JP
Japan
Prior art keywords
pharmaceutical
pharmaceutical formulation
preparation
amount
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017545684A
Other languages
English (en)
Japanese (ja)
Other versions
JP6566531B2 (ja
JP2018506575A (ja
Filing date
Publication date
Priority claimed from US14/796,686 external-priority patent/US9351945B1/en
Application filed filed Critical
Publication of JP2018506575A publication Critical patent/JP2018506575A/ja
Publication of JP2018506575A5 publication Critical patent/JP2018506575A5/ja
Priority to JP2019137319A priority Critical patent/JP6920379B2/ja
Application granted granted Critical
Publication of JP6566531B2 publication Critical patent/JP6566531B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017545684A 2015-02-27 2016-02-24 脂肪組織の減少 Active JP6566531B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019137319A JP6920379B2 (ja) 2015-02-27 2019-07-25 脂肪組織の減少

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562121927P 2015-02-27 2015-02-27
US62/121,927 2015-02-27
US201562165716P 2015-05-22 2015-05-22
US62/165,716 2015-05-22
US14/796,686 2015-07-10
US14/796,686 US9351945B1 (en) 2015-02-27 2015-07-10 Reduction of adipose tissue
PCT/US2016/019366 WO2016138136A1 (en) 2015-02-27 2016-02-24 Reduction of adipose tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019137319A Division JP6920379B2 (ja) 2015-02-27 2019-07-25 脂肪組織の減少

Publications (3)

Publication Number Publication Date
JP2018506575A JP2018506575A (ja) 2018-03-08
JP2018506575A5 true JP2018506575A5 (enExample) 2019-04-04
JP6566531B2 JP6566531B2 (ja) 2019-08-28

Family

ID=56027678

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017545684A Active JP6566531B2 (ja) 2015-02-27 2016-02-24 脂肪組織の減少
JP2019137319A Active JP6920379B2 (ja) 2015-02-27 2019-07-25 脂肪組織の減少

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019137319A Active JP6920379B2 (ja) 2015-02-27 2019-07-25 脂肪組織の減少

Country Status (9)

Country Link
US (6) US9351945B1 (enExample)
EP (2) EP3261646B1 (enExample)
JP (2) JP6566531B2 (enExample)
KR (4) KR20200084903A (enExample)
CN (2) CN107530359B (enExample)
AU (1) AU2016222802B2 (enExample)
CA (1) CA2977960C (enExample)
ES (2) ES2970312T3 (enExample)
WO (1) WO2016138136A1 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US12102473B2 (en) 2008-06-06 2024-10-01 Ulthera, Inc. Systems for ultrasound treatment
KR102479936B1 (ko) 2008-06-06 2022-12-22 얼테라, 인크 초음파 치료 시스템
CA2748362A1 (en) 2008-12-24 2010-07-01 Michael H. Slayton Methods and systems for fat reduction and/or cellulite treatment
WO2011075676A2 (en) 2009-12-18 2011-06-23 Knowlton Edward W A skin treatment and drug delivery device
US20160317170A1 (en) 2013-12-06 2016-11-03 Edward KNOWLTON Pixel array medical systems, devices and methods
US10368904B2 (en) 2013-12-06 2019-08-06 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10695546B2 (en) 2010-12-17 2020-06-30 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
US11000310B2 (en) 2010-12-17 2021-05-11 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11278309B2 (en) 2010-12-17 2022-03-22 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11103275B2 (en) 2010-12-17 2021-08-31 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10736653B2 (en) 2013-12-06 2020-08-11 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10702684B2 (en) 2010-12-17 2020-07-07 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
US10772658B2 (en) 2010-12-17 2020-09-15 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10967162B2 (en) 2010-12-17 2021-04-06 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
CN204637350U (zh) 2013-03-08 2015-09-16 奥赛拉公司 美学成像与处理系统、多焦点处理系统和执行美容过程的系统
CA2926322C (en) 2013-10-02 2022-10-18 Srgi Holdings, Llc Pixel array medical devices and methods
ES2827049T3 (es) 2013-10-02 2021-05-19 Srgi Holdings Llc Dispositivos médicos de conjunto de píxeles
US11229452B2 (en) 2013-12-06 2022-01-25 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11937846B2 (en) 2013-12-06 2024-03-26 Srgi Holdings Llc Pixel array medical systems, devices and methods
US20170028227A1 (en) 2014-04-18 2017-02-02 Ulthera, Inc. Band transducer ultrasound therapy
US9351945B1 (en) * 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
US11490952B2 (en) 2015-08-31 2022-11-08 Srgi Holdings, Llc Pixel array medical devices and methods
US11751903B2 (en) 2015-08-31 2023-09-12 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11980389B2 (en) 2015-08-31 2024-05-14 Srgi Holdings Llc Handed spiral slotted scalpet array
PT3405294T (pt) 2016-01-18 2023-03-03 Ulthera Inc Dispositivo de ultrassom compacto com matriz anular de ultrassom ligada eletricamente de modo periférico a placa de circuito impresso flexível
US11564706B2 (en) 2019-10-28 2023-01-31 Srgi Holdings, Llc Pixel array medical systems, devices and methods
EP3251654A1 (de) 2016-05-30 2017-12-06 Chemische Fabrik Kreussler & Co. Gmbh Nichtionische tenside zur reduktion von fettgewebe
CN109562279B (zh) 2016-08-16 2022-03-15 奥赛拉公司 用于皮肤的美容超声治疗的系统和方法
ES2886651T3 (es) * 2016-10-28 2021-12-20 Merz Pharma Gmbh & Co Kgaa Tratamiento cosmético de la celulitis
TW202529848A (zh) 2018-01-26 2025-08-01 美商奧賽拉公司 用於多個維度中的同時多聚焦超音治療的系統和方法
WO2019164836A1 (en) * 2018-02-20 2019-08-29 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound
IT201800006109A1 (it) 2018-06-07 2019-12-07 Polidocanolo per uso come immunomodulatore
WO2020081590A1 (en) 2018-10-16 2020-04-23 Rotunda Adam M Alcohol-based compositions and uses thereof
US11986443B2 (en) * 2018-10-16 2024-05-21 Polithera, Inc. Alcohol-based compositions and uses thereof
US20210000760A1 (en) * 2018-10-16 2021-01-07 Polithera, Inc. Alcohol-based compositions and uses thereof
CA3116332A1 (en) 2018-11-30 2020-06-04 Ulthera, Inc. Systems and methods for enhancing efficacy of ultrasound treatment
TWI864044B (zh) 2019-07-15 2024-12-01 美商奧賽拉公司 用於利用多維度的超音波多焦點剪切波的成像來測量彈性的系統和方法
KR102937196B1 (ko) 2020-07-09 2026-03-09 주식회사 엘지에너지솔루션 통신 시스템 및 방법
EP3973951A1 (en) * 2020-09-23 2022-03-30 Polithera, Inc. Alcohol-based compositions and uses thereof
WO2025101049A1 (ko) * 2023-11-07 2025-05-15 (주)시지바이오 지방분해주사제 조성물
AU2024396088A1 (en) * 2023-12-04 2026-06-18 Leios Therapeutics, Inc. Reduction of adipose tissue

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267169A (en) * 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
US5164320A (en) * 1990-03-05 1992-11-17 Becton, Dickinson And Company Method for lysing hard liposomes using polyethyleneglycol mono-n-alkyl ethers
DE69224294T2 (de) 1991-10-16 1998-08-20 Richardson Vicks Inc Verbesserte hautpenetrationssysteme fuer erhoehte topische freisetzung von arzneimitteln
BR9306816A (pt) 1992-07-28 1998-12-08 Procter & Gamble Composição farmaceutica para uso tópico contendo um polímero catiônico reticulado e um eter alcoxilado
ES2068151B1 (es) 1993-06-23 1995-11-16 Cabrera Garrido Juan Microespuma inyectable para esclerosis.
US5681552A (en) 1995-05-23 1997-10-28 The Mennen Company Clear cosmetic stick composition containing a combination of anionic and non-ionic surfactants
JP4335316B2 (ja) 1996-09-19 2009-09-30 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン アルギネートまたは修飾アルギネートのようなポリサッカライドを含むポリマー
JP5062708B2 (ja) * 1998-02-24 2012-10-31 株式会社マンダム 防腐殺菌剤及び人体施用組成物
US7494488B2 (en) 1998-05-28 2009-02-24 Pearl Technology Holdings, Llc Facial tissue strengthening and tightening device and methods
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
CH693625A5 (it) 1999-02-18 2003-11-28 Inpharma Sa Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi.
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
GB0028692D0 (en) 2000-11-24 2001-01-10 Btg Int Ltd Generation of therapeutic microform
DE50101401D1 (de) 2001-06-11 2004-03-04 Filtertek Bv Kombinationsfilter-Anordnung
US20030216364A1 (en) 2001-08-13 2003-11-20 Johnson Keith Arthur Dermatological Formulation
DE10158199A1 (de) * 2001-11-27 2003-06-18 Beiersdorf Ag Juckreizstillende kosmetische und dermatologische Zubereitungen
JP4387639B2 (ja) 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
WO2004051549A2 (en) 2002-12-02 2004-06-17 Allergan, Inc. Active agent delivery method
GB0307869D0 (en) 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US20080069779A1 (en) 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
GB0321210D0 (en) 2003-09-10 2003-10-08 Btg Int Ltd Apparatus and method for dispensing foam
DE10349979B4 (de) 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Medikamentöse gezielte lokale Lipolyse
US20050089555A1 (en) 2003-10-24 2005-04-28 Aventis Pharma Deutschland Gmbh Medicinal targeted local lipolysis
WO2005046746A2 (en) 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
WO2005048976A2 (en) * 2003-11-17 2005-06-02 Btg International Limited Foams comprising a sclerosing and a viscosity enhancing agent, methods for production thereof
US20050143347A1 (en) 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
NZ589967A (en) 2004-01-14 2012-07-27 Gilead Sciences Inc Lipid-based dispersions useful for drug delivery
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US7727537B2 (en) 2005-02-14 2010-06-01 Dpm Therapeutics Corp. Stabilized compositions for topical administration and methods of making same
WO2006133876A1 (en) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Use of pyrimidine derivatives for cosmetic purposes
DE102005037844A1 (de) 2005-08-04 2007-04-05 Intendis Gmbh Wasserfreies Mehr-Phasen-Gel-System
DE102005039579B4 (de) 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
CN100364546C (zh) * 2005-09-16 2008-01-30 陕西天宇制药有限公司 聚桂醇注射液及其制备方法
US20070135343A1 (en) * 2005-11-01 2007-06-14 Wyeth Sodium chloride solution for drug reconstitution or dilution
US20090214657A1 (en) 2005-11-30 2009-08-27 Muhammad Waseem Tahir Qazi Orally Absorbed Pharmaceutical Formulation and Method of Administration
CN101626759B (zh) * 2006-10-17 2014-08-06 利特拉公司 用于治疗甲状腺眼病的组合物和制剂
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
AU2007356328A1 (en) 2006-11-14 2009-01-15 Tal Berman Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
GB0623838D0 (en) 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
EP1970051A1 (en) 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
US20100144890A1 (en) 2007-01-17 2010-06-10 Peter Boderke Use of a surfactant for the preparation of a formulation for the treatment of adipose diseases
EP1946746A1 (en) 2007-01-17 2008-07-23 Merz Pharma GmbH & Co. KGaA Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases
DE102007015701A1 (de) * 2007-03-19 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung
NZ582049A (en) 2007-05-18 2012-12-21 Tti Ellebeau Inc Transdermal delivery devices assuring an improved release of an active principle through a biological interface
US20080294072A1 (en) 2007-05-24 2008-11-27 Crutchfield Dermatology Mesotherapy with ultrasound
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US20100189721A1 (en) * 2007-07-06 2010-07-29 Smithkline Beecham Corporation Antibody formulations
US20090202467A1 (en) 2008-02-08 2009-08-13 Bock Richard W Sclerotherapy for varicose veins
KR20090116981A (ko) * 2008-05-08 2009-11-12 (주)와이즈덤레버러토리 석류피 추출물을 유효성분으로 포함하는 면역반응 조절을통한 탈모 방지 및 치료용 조성물
TWM351548U (en) 2008-07-17 2009-02-21 Wistron Corp Oscillating power generator with a ratchet mechanism
EP2369956A1 (en) 2008-10-22 2011-10-05 Allergan, Inc. Clinical assessment scales and methods
WO2010096868A1 (en) 2009-02-25 2010-09-02 Stiefel Research Australia Pty Ltd Topical foam composition
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2471518B1 (en) 2009-05-18 2017-08-23 Sigmoid Pharma Limited Composition comprising oil drops
CN105919832A (zh) 2010-06-11 2016-09-07 宝洁公司 用于处理皮肤的组合物
US20120016347A1 (en) 2010-07-13 2012-01-19 Shipp John I Seroma Control for Surgical Patients
EP2593093A1 (en) 2010-07-16 2013-05-22 Merz Pharma GmbH & Co. KGaA Use of a cationic amphiphilic drug for the preparation of a formulation for the reduction of subcutaneous adipose tissue
MX2013009842A (es) 2011-03-01 2014-03-12 Merz Pharma Gmbh & Co Kgaa Composicion que comprende receptor gamma activado por proliferador de peroxisoma.
US9241921B2 (en) 2011-05-02 2016-01-26 Pankaj Modi Photosensitizer composition for treating skin disorders
CN102198089A (zh) * 2011-05-19 2011-09-28 陕西天宇制药有限公司 聚桂醇注射液作为治疗内痔药物的应用
BR112014013227A2 (pt) 2011-11-30 2017-06-13 Merz Pharma Gmbh & Co Kgaa uso de álcoois peguilados no tratamento de queratose actínica
WO2014164815A2 (en) * 2013-03-12 2014-10-09 Allergan, Inc. Adipose tissue combinations, devices, and uses thereof
CN103191146B (zh) * 2013-04-22 2015-05-13 福建医科大学附属协和医院 一种高效无痛的肿瘤局部消融治疗药物
US10016449B2 (en) * 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
US20140356968A1 (en) * 2013-06-04 2014-12-04 Therapeutic Proteins International, LLC Methods for comparing a structure of a first biomolecule and a second biomolecule
US9351945B1 (en) * 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
EP3251654A1 (de) * 2016-05-30 2017-12-06 Chemische Fabrik Kreussler & Co. Gmbh Nichtionische tenside zur reduktion von fettgewebe

Similar Documents

Publication Publication Date Title
JP2014129360A5 (enExample)
JP2017105763A5 (enExample)
JP2014139229A5 (enExample)
EA202190115A1 (ru) Пленочные составы, содержащие дексмедетомидин, и способы их получения
EA201790989A1 (ru) Стабильный препарат раствора белка, содержащего анти-vegf антитело в высокой концентрации
FI3562486T3 (fi) Kielenalaisen deksmedetomidiinin käyttö agitaation hoidossa
JP2016540809A5 (enExample)
JP2015098469A5 (enExample)
MX378901B (es) Formulaciones liquidas estables de virus de vacuna.
WO2018089328A8 (en) TREATMENT OF CNS DISEASES USING GCS STIMULATORS
HK1251481A1 (zh) 使用白介素-17(il-17)拮抗剂治疗放射学阴性中轴型脊柱关节炎的方法
RU2017101833A (ru) Орально распадающийся пленочный препарат, содержащий тадалафил, и способ его приготовления
JP2016510747A5 (enExample)
PE20211805A1 (es) Formulaciones de un inhibidor de axl/mer
JP2022511335A5 (enExample)
PH12015502717A1 (en) Anti-fibrogenic compounds, methods and uses thereof
JP2016534062A5 (enExample)
RU2015134148A (ru) Галеновая форма для введения активного действующего вещества
JP2015511618A5 (enExample)
JP2018503629A5 (enExample)
WO2019087133A8 (en) Method of treating tendinopathy using interleukin-17 (il-17) antagonists
JP2016508138A5 (enExample)
HRP20201844T1 (hr) Biodostupni poliamini
WO2016008401A8 (zh) 一种含多西他赛的药物组合物
FI3263106T3 (fi) Menetelmä kinoliinijohdannaisen kitkeryyden tukahduttamiseksi